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Abstract 
 
Background : Pneumonia is more commonly among children under five years old and caused 
by several risk factors. Pneumonia causes 1.9 – 2.2 million children death worldwide every year, 
in which 1.3 million (81%) generally occurs in first 2 years of life. Seventy two percent of 
pneumonia occurs in children under five years old in 15 countries.  Indonesia was the 7th highest 
in the world. The prevalence of pneumonia in Indonesia was 18.5/1000 population and only 
1.6/1000 received treatment. Objective of the study is to elaborate the risk factors of the influenza 
related pneumonia in children under five years old. 
Method : The pneumonia control program in Ministry of Health focuses on early detection and 
treatment for bacterial pneumonia in community. Severe acute respiratory infection (SARI) can 
develop fatal pneumonia. We collected data from the pneumonia surveillance database in the 
Acute Respiratory Infection sub directorate.  
Results : Influenza related pneumonia was 13% of acute lower respiratory infection in pediatric. 
The number of children under five years old death estimation was   28,000-115,000 and 99% 
happened in developing countries.  
Conclusion : In Indonesia, proportion of influenza from SARI surveillance was 12% and mainly 
in children under five years old (36%).  Pneumonia was 18% of SARI cases with positive 
influenza. The effect of Influenza become pneumonia remain unclear. 
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Abstrak 
 
Latar Belakang : Pneumonia lebih sering terjadi pada anak-anak di bawah lima tahun dan 
disebabkan oleh beberapa faktor risiko. Pneumonia menyebabkan 1,9 - 2,2 juta kematian anak-
anak di seluruh dunia setiap tahun, di mana 1,3 juta (81%) umumnya terjadi pada 2 tahun 
pertama kehidupan. Tujuh puluh dua persen pneumonia terjadi pada anak-anak di bawah lima 
tahun di 15 negara. Indonesia adalah yang tertinggi ke-7 di dunia. Prevalensi pneumonia di 
Indonesia adalah 18,5 / 1000 populasi dan hanya 1,6 / 1000 yang menerima pengobatan. Tujuan 
dari penelitian ini adalah untuk menguraikan faktor risiko pneumonia terkait influenza pada anak-
anak di bawah lima tahun. 
Metode: Program pengendalian pneumonia di Kementerian Kesehatan berfokus pada deteksi 
dini dan pengobatan untuk pneumonia bakteri di masyarakat. Infeksi pernapasan akut yang berat 
(SARI) dapat menyebabkan pneumonia yang fatal. Kami mengumpulkan data dari database 
pengintaian pneumonia di subdirektorat Infeksi Saluran Pernapasan Akut. 
Hasil : Influenza terkait pneumonia adalah 13% dari infeksi saluran pernapasan akut bawah pada 
anak. Jumlah perkiraan kematian balita adalah 28.000-115.000 dan 99% terjadi di negara 
berkembang.  
Kesimpulan : Di Indonesia, proporsi influenza dari surveilans SARI adalah 12% dan terutama 
pada anak-anak di bawah lima tahun (36%). Pneumonia adalah 18% kasus SARI dengan 
influenza positif. Efek influenza menjadi pneumonia tetap tidak jelas. 
 
Kata kunci : Pneumonia, Influenza, SARI, balita 
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INTRODUCTION  
Severe acute respiratory infection 
(SARI) can develop progressive pneumonia 
in few hours and cause fatal pneumonia in 
children under five years old. Pneumonia 
remains the most cause of death in children 
under five years old worldwide. Of 5.9 million 
children death globally, pneumonia was 
16%.  72% of pneumonia has happened in 
15 countries.  Indonesia was in 7th rank.1 
World Health Organization (WHO) estimated 
1.9-2.2 millions children death from acute 
respiratory infection (ARI) every year.2,3 
Pneumonia as cause of death in 1.3 million 
children under five years old and 81% death 
occurred in two years of first life.4 According 
to Demography Health Survey 2012, infant 
mortality rate in Indonesia was 32/1000 live 
births and under five years old mortality rate 
was 40/1000 live births. Proportion of 
pneumonia death was 9.4%. Basic Health 
Survey (2013) got periods prevalence of 
pneumonia under five years old 18.5/1000 
population and the children who got 
treatment only 1.6/1000.5,6  
New emerging respiratory virus is 
potential become global health security 
threat such as Severe acute respiratory 
syndrome/ SARS, Avian influenza H5N1, 
H7N9, H1N1pdm09, Human Adenovirus-14 
and Middle East Respiratory 
Syndrome/MERS CoV.7–9 One of  SARI 
caused is  influenza virus as important 
pathogen in public health. Influenza is also 
zoonotic infection such as Avian Influenza 
that circulates endemic in poultry, sometimes 
evoke an outbreak in human and can result 
pandemic. The most common prevalence of 
Influenza in school age children but  the 
severe disease can happen  in  infant, elderly 
people, and high risk person with 
comorbid.10,11 Seasonal influenza was 
second common caused in children with 
pneumonia and substantial contribute to 
hospital admission and cause of death in 
children under five years old.4,12 Experience 
from influenza pandemic H1N1 2009 lead 
many countries including Indonesia, to raise 
pandemic awareness through Influenza Like 
Illness/ ILI and SARI surveillance. SARI was 
clinical syndrome of acute respiratory 
infection that caused by influenza virus or 
other pathogens.10  
In high risk people such as children, 
elderly people, and chronic disease, 
influenza can be severe and fatal. There 
were about 3-5 million severe cases and 
250-500 thousand of death every year.13 
Influenza outbreak can reached more than 
49,000 of death and 200,000 people need 
hospital admission every year, only in 
USA.11 WHO estimated 20% of hospitalized 
children under five years old with SARI and 
90% of SARI was pneumonia. Some studies 
in several country along with WHO, showed 
that Influenza has biggest proportion in 
children under five years old with SARI.13–15 
Countries with four seasons like 
Europe and America have more clearly 
influenza data and the peak of Influenza was 
in winter. But the information was limited in 
tropical and subtropical developing 
countries. In WHO South East Asian Region 
(SEAR), influenza with severe pneumonia 
episode 273 thousand (78-1094 thousand) 
and proportion of severe cases was 5%, 
while death was about 49 thousand and 
proportion was 11.1%.4 In Indonesia, 
Influenza were identified 20.1% of ILI cases 
and 21.7% of SARI cases in  2003-2007.16 In 
2011, influenza positive were confirmed 6% 
of SARI cases.17 In 2013-2015, influenza 
positive were confirmed 11.8% of SARI 
cases from six hospital sentinel site and 15% 
were pneumonia.  40% of influenza positive 
were in age group 1-4 years.18,19 This 
proportion was high enough but still influenza 
related pneumonia was unrecognized and 
underreporting as well. Objective of the study 
is to elaborate the risk factors of the influenza 
related pneumonia in children under five 
years old. 
 
METHOD  
The pneumonia control program in 
Ministry of Health focuses on early detection 
and treatment for bacterial pneumonia in 
community. Severe acute respiratory 
infection (SARI) can develop fatal 
pneumonia. We collected data from the 
pneumonia surveillance database in the 
Acute Respiratory Infection sub directorate. 
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RESULTS  
 
Etiology 
Pneumonia can be caused by 
bacteria, virus,  fungi and  can caused by 
other things such as radiation, aspiration.2,20 
The most common bacteria were 
Streptococcus pneumoniae (30-50%) and 
Haemophilus influenzae (10-30%) and both 
of them can be prevented by vaccine.  In 
some severe cases caused by 
Staphylococcus aureus and Klebsiella 
pneumoniae.9,21,22 The most common virus 
were Respiratory Syncytial virus/ RSV in 15-
40% hospitalized pneumonia in developing 
countries, followed by Influenza A and B, 
parainfluenza, Human metapnemovirus and 
adenovirus.9,21 
 
Risk Factors 
Definite risk factors were age less 
than two years, asplenia or hyposplenia, 
diabetes, Influenza, HIV, humoral immune 
defect, malnutrition, low birth weight, 
inadequate breast feeding, no measles 
vaccine, indoor air pollution and crowding. 
The likely risk factors were chronic diseases 
(asthma, neurologic disorder, tuberculosis), 
zinc deficiency, concomitant diseases, 
poverty, mother experience, mother age. 
The possible risk factor were mother low 
education, child day care, vitamin A 
deficiency, humidity, latitude, cold weather 
and outdoor air pollution.13,20–22,23–26 
 
Symptoms 
Mostly, people with mild Influenza 
has mild symptom and recovery in two 
weeks. Some will develop to severe outcome 
and need hospitalization. The highest 
severity was in infant and who have 
comorbid diseases. Acute symptoms and 
fever often persist for 7 to 10 days. 
Weakness and fatigue may linger for weeks. 
Influenza usually occurs in winter outbreaks 
or epidemics (in temperate climates).  
Fulminant fatal influenza viral pneumonia 
occasionally occurs; dyspnea, cyanosis, 
hemoptysis, pulmonary edema, and death 
may proceed in as little as 48 hours after the 
onset of symptoms.24 
DISCUSSIONS  
Seasonal influenza circulates 
worldwide but only influenza A and B can 
cause outbreak in human and have vaccine 
to prevent it. Influenza A is more important 
pathogen that cause seasonal, endemic 
infections and periodic, unpredictable 
pandemics.13,27,28 According to seasonality, 
common pattern of RSV and Influenza were 
highest in rainy season, although Influenza 
circulates around the year.9,19 
Pneumonia caused by combined of risk 
factors that associate with host, infection and 
environment.21 Influenza risk factors were 
children under five years old particularly 
children less than two years old, person with 
comorbid such as chronic lung diseases, 
hearth diseases, liver disease, kidney 
disease, diabetes, asthma, neurological 
disorders, blood  disorders, HIV/AIDS, 
immune deficiency, obesity.13,26 
Co-pathogenesis between influenza 
and superinfection bacteria was based on 
multifactor. Virulence factor that showed 
virus has specific strain effect on host that 
which allows bacterial infection caused 
pneumonia. Influenza virus cause multiple 
changes in lung that can caused secondary 
bacterial invasion. Epithelial cells damaged, 
surfactant disruption, cell pieces into airway 
become access and source of nutrition to 
bacteria growth. Airway physiology changes 
reduce oxygen exchange, airway hyper 
reactive and reduce bacteria cleaning 
mechanism. Influenza virus can facilitate 
bacteria from upper respiratory inhale and 
invasion to lower respiratory.29 Influenza A 
viral replication peaks approximately 48 
hours after inoculation into the nasopharynx 
and declines slowly, with little virus shed after 
about six days. The virus replicates in both 
the upper and lower respiratory tract. Even 
after the infectious virus can no longer be 
recovered, viral antigen can be detected in 
cells and secretions of infected individuals 
for several days. Non-fatal influenza viral 
infection predominantly involves the upper 
respiratory tract and trachea, but fatal cases 
of influenza usually show evidence of 
pneumonia.24 
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In pneumonia, alveoli filled with pus 
and fluid that cause disturbed oxygen 
exchange and dyspnea. Lung compliance 
reduce and will manifest as fast breathing. If 
condition getting worst, lung will more rigid 
and chest retraction appear. Viral infection 
signed by mononuclear cell accumulation in 
sub mucous and perivascular room that 
produce airway partial obstruction. Alveolar 
type II cell damage and surfactant production 
reduce so that appears hyaline membrane 
and lung edema.6,29,30 
Influenza can be manifest as 
asymptomatic to serious illness with 
systemic symptoms.   Seasonal influenza 
has sudden onset of fever (38-40˚C), cough, 
muscle ache, joint pain, sore throat and cold. 
Pneumonia can develop in few hours, 
usually caused by secondary infection. 
Pneumonia symptoms were dyspnea, 
cyanosis, lung edema, acute respiratory 
distress syndrome and death can process in 
48 hours after the onset. Hospitalization and 
death depend on some factors that 
accompany such as age and comorbid 
(asthma, pulmonary disease, cardiovascular 
disease, neurological disorder, metabolic 
disorder).11,13,22,24,30–32 
In Indonesia, pneumonia diagnosis 
base on clinical condition such as fast 
breathing and chest retraction. Age divided 
according to Integrated Management of 
Childhood Illness (IMCI) age group to 
determine fast breathing. The classification 
pneumonia by fast breathing which were age 
<2 months: ≥60 times/ minute; age 2-<12 
months: ≥50 times/ minute; age 12-<60 
months: ≥40 times/minute.6,33 Chest X-ray, 
blood test and culture, rapid diagnostic test 
for pneumococcal with 
immunochromatography assay, reverse 
transcriptase polymerase chain reaction/ RT-
PCR, DNA assay as supporting examination 
can be used if available. Chest X-ray was 
unable to differentiate bacteria or virus. 
10,20,22,26,34–36 Ultrasonography (USG) can 
diagnose accurately pneumonia cases in 
children and adolescence and can replace 
Chest X-ray for diagnoses.30 The diagnostic 
method such as Polymerase Chain Reaction 
(PCR) enhance new virus detection and 
vaccine for pneumococcal and Haemophilus 
influenzae reduce bacterial pneumonia and 
increase virus pneumonia.9 
Mostly, Influenza is mild and recovery 
in two weeks with supportive treatment such 
as nutrition and liquid and home care. 
Grossly, the children that treat as outpatient 
get oral antibiotic. In randomized study, 820 
mild pneumonia in children with Amoxicillin 
50 mg/weight two times a day as effective as 
three times a day. Nutrition for severe 
pneumonia or respiratory distress give 
through nasogastric tube or intravenous line. 
Tight monitoring is needed to avoid 
overhydration.26 Intravenous antibiotic such 
as Ampicillin or cephalosporin give to 
inpatient patient depend on local resistance. 
26,30 Treatment for Community Acquired 
Pneumonia were optimum supportive and 
effective antibiotic as soon as possible. 
Supportive treatments were oxygen, 
ventilator, volume resuscitation, 
vasopressor, nutrition can save life.20,22 
According to Ministry of Health, severe 
pneumonia in health care center 
(Puskesmas) must refer to hospital as soon 
as possible after give prompt treatment such 
as oxygen, antibiotic first dose, antipyretic 
and other supportive drugs if available.6 
Length of stay in pneumonia with 
abnormality of chest X-ray longer than 
normal chest X-ray.35 
Antiviral for influenza can be used as 
treatment and prophylaxis to reduce serious 
complication and death.24 Ideally, antiviral 
given in first 48 hours since the onset. There 
were two class of drugs. First, Matrix 2 ion 
channel blocker (Adamantanes) which were 
Amantadine and Rimantadine, but about one 
third patient has drug resistant. Second, 
Inhibitor Neuraminidase consist of 
Oseltamivir and Zanamivir, while Peramivir 
and Laninamivir only have license in several 
countries. Oseltamivir dose in age 0-8 
months was 6 mg/kg body weight per day, 
divided in 2 doses; age 9-23 months: 7 mg/kg 
body weight per day, divided in 2 doses; ≥24 
months : 4 mg/kg body weight per day, 
divided in 2 doses; premature baby: 2 mg/kg 
body weight per day, divided in 2 doses for 5 
days.34  
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Pneumococcal vaccine was 
recommended for age 7-12 months and 
given twice with 2 months interval. For age 
>1 year, it is given one time. Both age groups 
need booster one times after age >1 year or 
two months after the last time vaccine. For 
age >2 year only gives one times.24,37 
Children were primary reservoir for 
pneumococcal colonization in human, and 
eliminate carrier status will reduce 
transmission to population.22 
Influenza vaccine was recommended 
for children more than 6 months. Vaccinne 
was give protection for several months 
normally, because virus mutation gradually 
make population immune disappear after 
several years. Booster vaccine are 
recommend for high risk people.24 The most 
effective influenza vaccine if similar with 
circulate virus. WHO is always update 
vaccine compositions every two years. Since 
2013-2014, quadrivalent vaccine 
compositions has been recomended to give 
more protection.13 
Influenza virus changes constantly and 
need surveillance to monitor virus influenza 
in human. Influenza surveillance is important 
to early detection and evaluate new virus 
variance or subtype.13 ILI and SARI 
Surveillance were used WHO guidelines for 
case definition. Because of limited 
resources, many countries use sentinel 
surveillance to monitor Influenza. ILI 
surveillance is for monitor outpatient and 
SARI surveillance is to monitor inpatient.10 
According to International Health 
regulation/IHR, every country should report 
influenza data to WHO through FluNet for 
laboratory result data and FluId for 
epidemiology data.10,38–40  
Indonesia has SARI surveillance called 
as Surveilans ISPA Berat Indonesia (SIBI). 
SIBI has developed according WHO 
guidelines since 2013 in six sentinel 
hospitals around Indonesia. The sentinel 
hospital were RSUD Deli Serdang, RSUD 
Wonosari, RSU Kanudjoso Djatiwibowo, 
RSUD Bitung, RSUP NTB, RSU Dr. 
Haullussy Ambon. As a model, SIBI in the 
future can be expanded for other emerging 
respiratory  infection in order to pandemic 
preparedness and awareness.41,42 
 
CONCLUSION 
Pneumonia remains high morbidity and 
mortality in children under five years old. 
Influenza is important caused of pneumonia 
and need to monitor through surveillance. 
Influenza has high proportion in children 
under five years old in Indonesia. The effect 
of influenza related pneumonia is still 
unclear. 
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